TTC14 antibody
Principal name
TTC14 antibody
Alternative names for TTC14 antibody
KIAA1980, Tetratricopeptide repeat protein 14, TPR repeat protein 14
Ncbi ID
NP_597719, ACE87800.1, NP_597719.1, NM_133462, NM_025978, NM_027619, NP_080254.2
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of TTC14 antibody
- Kit Component:
- - KN207026G1, TTC14 gRNA vector 1 in pCas-Guide vector
- KN207026G2, TTC14 gRNA vector 2 in pCas-Guide vector
- KN207026D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Clark,H.F., (2003) Genome Res. 13 (10), 2265-2270
Human Jurkat; WB Suggested Anti-TTC14 Antibody Titration: 0.2-1 ug/ml. Positive Control: Jurkat cell lysate; TTC14 antibody - N-terminal region (ARP41101_P050) in Human Jurkat cells using Western Blot
Transfected 293T; WB Suggested Anti-TTC14 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Transfected 293T; TTC14 antibody - N-terminal region (ARP41100_P050) in Transfected 293T cells using Western Blot
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TTC14 (RC207026, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-TTC14.(1:2000)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-TTC14 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120°C for 3 min, TA808788)(1:150)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human liver tissue using anti-TTC14 mouse monoclonal antibody.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120°C for 3 min, TA808788)(1:150)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-TTC14 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120°C for 3 min, TA808788)(1:150)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TTC14 (RC207026, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-TTC14.(1:2000)
WB Suggested Anti-TTC14 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 62500; Positive Control: Transfected 293T
WB Suggested Anti-TTC14 Antibody Titration: 0.2-1 ug/ml; Positive Control: Jurkat cell lysate
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA808788 | TTC14 antibody |
||||||
| TTC14 mouse monoclonal antibody, clone OTI9E11 (formerly 9E11) | |||||||
 |
Mouse | IgG1 | OTI9E11 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +3 additional images |
Highly validated antibody!
|
||||||
| TA808787 | TTC14 antibody |
||||||
| TTC14 mouse monoclonal antibody, clone OTI1G9 (formerly 1G9) | |||||||
 |
Mouse | IgG1 | OTI1G9 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY408799 | TTC14 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR218460L2V | Lenti ORF particles, Ttc14 (GFP-tagged) - Mouse tetratricopeptide repeat domain 14 (Ttc14), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,560.00
|
|
| OriGene Technologies, Inc. | ||
| MR206986L2V | Lenti ORF particles, Ttc14 (GFP-tagged) - Mouse tetratricopeptide repeat domain 14 (Ttc14), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,100.00
|
|
| OriGene Technologies, Inc. | ||
| MR218460L1V | Lenti ORF particles, Ttc14 (Myc-DDK-tagged) - Mouse tetratricopeptide repeat domain 14 (Ttc14), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,400.00
|
|
| OriGene Technologies, Inc. | ||
| MR206986L1V | Lenti ORF particles, Ttc14 (Myc-DDK-tagged) - Mouse tetratricopeptide repeat domain 14 (Ttc14), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€990.00
|
|
| OriGene Technologies, Inc. | ||